{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:59:48Z","timestamp":1780059588890,"version":"3.54.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,4]]},"DOI":"10.7759\/cureus.106442","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T02:44:21Z","timestamp":1775357061000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Nondiabetic Hypoglycemia After Risperidone Initiation in an Adult With Schizophrenia: A Case Report and Systematic Review"],"prefix":"10.7759","author":[{"given":"Aditi","family":"Sarker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Substance Abuse and Mental Health Services Administration. Impact of the DSM-IV to DSM-5 changes on the National Survey on Drug Use and Health. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2016. Table 3.22, DSM-IV to DSM-5 schizophrenia comparison. Available from","author":"Substance Abuse and Mental Health Services Administration","year":"2016","unstructured":"Substance Abuse and Mental Health Services Administration. Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration, Rockville, MD; 2016. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519704\/table\/ch3.t22\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.MY20096AH1C","article-title":"Treatment-resistant schizophrenia: definition, predictors, and therapy options","volume":"82","author":"Correll CU","year":"2021","unstructured":"Correll CU, Howes OD. Treatment-resistant schizophrenia: definition, predictors, and therapy options. J Clin Psychiatry. 2021, 82:10.4088\/JCP.MY20096AH1C","journal-title":"J Clin Psychiatry"},{"key":"ref3","article-title":"Future research needs for first- and second-generation antipsychotics for children and young adults","author":"Christian R","year":"2012","unstructured":"Christian R, Saavedra L, Gaynes BN, et al.. Future research needs for first- and second-generation antipsychotics for children and young adults. Agency for Healthcare Research and Quality, Rockville, MD; 2012."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240738","article-title":"Antipsychotic drugs: a concise review of history, classification, indications, mechanism, efficacy, side effects, dosing, and clinical application","volume":"181","author":"Leucht S","year":"2024","unstructured":"Leucht S, Priller J, Davis JM. Antipsychotic drugs: a concise review of history, classification, indications, mechanism, efficacy, side effects, dosing, and clinical application. Am J Psychiatry. 2024, 181:865-78. 10.1176\/appi.ajp.20240738","journal-title":"Am J Psychiatry"},{"key":"ref5","article-title":"Risperidone","author":"McNeil SE","year":"2025","unstructured":"McNeil SE, Gibbons JR, Cogburn M. Risperidone. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnma.2022.09.010","article-title":"Risperidone induced hypotension: a case report and literature review","volume":"114","author":"Nkemjika S","year":"2022","unstructured":"Nkemjika S, Singh S, Wayne K, Oforeh K, Saha A. Risperidone induced hypotension: a case report and literature review. J Natl Med Assoc. 2022, 114:621-3. 10.1016\/j.jnma.2022.09.010","journal-title":"J Natl Med Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-021-01000-1","article-title":"Second-generation antipsychotic drugs for patients with schizophrenia: systematic literature review and meta-analysis of metabolic and cardiovascular side effects","volume":"41","author":"Rognoni C","year":"2021","unstructured":"Rognoni C, Bertolani A, Jommi C. Second-generation antipsychotic drugs for patients with schizophrenia: systematic literature review and meta-analysis of metabolic and cardiovascular side effects. Clin Drug Investig. 2021, 41:303-19. 10.1007\/s40261-021-01000-1","journal-title":"Clin Drug Investig"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.17br02186","article-title":"Second-generation antipsychotic-induced hypoglycemia","volume":"20","author":"Fujita T","year":"2018","unstructured":"Fujita T, Mizoguchi Y, Kunitake Y, Tateishi H, Inaba T, Kato TA, Monji A. Second-generation antipsychotic-induced hypoglycemia. Prim Care Companion CNS Disord. 2018, 20:10.4088\/PCC.17br02186","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12416","article-title":"Severe hypoglycemia associated with risperidone","volume":"70","author":"Nagamine T","year":"2016","unstructured":"Nagamine T. Severe hypoglycemia associated with risperidone. Psychiatry Clin Neurosci. 2016, 70:421. 10.1111\/pcn.12416","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1805414","article-title":"Paliperidone-induced hypoglycemia by increasing insulin secretion","volume":"2016","author":"Omi T","year":"2016","unstructured":"Omi T, Riku K, Fukumoto M, Kanai K, Omura Y, Takada H, Matunaga H. Paliperidone-induced hypoglycemia by increasing insulin secretion. Case Rep Psychiatry. 2016, 2016:1805414. 10.1155\/2016\/1805414","journal-title":"Case Rep Psychiatry"},{"key":"ref11","article-title":"Hypoglycemia with atypical antipsychotics, but not with typical antipsychotics: a case report","volume":"11","author":"Ochi S","year":"2020","unstructured":"Ochi S, Abe M, Shimizu H, Iga JI, Ueno SI. Hypoglycemia with atypical antipsychotics, but not with typical antipsychotics: a case report. Clin Neuropsychopharmacol Ther. 2020, 11:5-8.","journal-title":"Clin Neuropsychopharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1792","article-title":"Hypoglycaemia induced by second generation antipsychotic agents in schizophrenic non-diabetic patients","volume":"338","author":"Suzuki Y","year":"2009","unstructured":"Suzuki Y, Watanabe J, Fukui N, Ozdemir V, Someya T. Hypoglycaemia induced by second generation antipsychotic agents in schizophrenic non-diabetic patients. BMJ. 2009, 338:a1792. 10.1136\/bmj.a1792","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3182557d10","article-title":"Oral aripiprazole-induced severe hypoglycemia","volume":"34","author":"Mondal S","year":"2012","unstructured":"Mondal S, Saha I, Das S, Ganguly A, Ghosh A, Kumar Das A. Oral aripiprazole-induced severe hypoglycemia. Ther Drug Monit. 2012, 34:245-8. 10.1097\/FTD.0b013e3182557d10","journal-title":"Ther Drug Monit"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/pcn5.162","article-title":"Recurrent reactive hypoglycemia due to clozapine-induced glucose intolerance: a case report","volume":"2","author":"Kawai F","year":"2023","unstructured":"Kawai F, Watanabe S, Ebihara H, et al.. Recurrent reactive hypoglycemia due to clozapine-induced glucose intolerance: a case report. PCN Rep. 2023, 2:e162. 10.1002\/pcn5.162","journal-title":"PCN Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/nedt.2006.2.4.583","article-title":"Hypoglycemia associated with insulin hypersecretion following the addition of olanzapine to conventional antipsychotics","volume":"2","author":"Nagamine T","year":"2006","unstructured":"Nagamine T. Hypoglycemia associated with insulin hypersecretion following the addition of olanzapine to conventional antipsychotics. Neuropsychiatr Dis Treat. 2006, 2:583-5. 10.2147\/nedt.2006.2.4.583","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-015-0203-5","article-title":"A case of hypoglycemia attributable to atypical antipsychotic drugs","volume":"6","author":"Ishiguro H","year":"2015","unstructured":"Ishiguro H, Hanyu O, Houya S, et al.. A case of hypoglycemia attributable to atypical antipsychotic drugs. Diabetol Int. 2015, 6:341-6. 10.1007\/s13340-015-0203-5","journal-title":"Diabetol Int"},{"key":"ref17","article-title":"Hypoglycemia","author":"Mathew P","year":"2026","unstructured":"Mathew P, Thoppil D. Hypoglycemia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097. 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"ref19","unstructured":"Joanna Briggs Institute. Critical appraisal checklist for case reports. (2017). https.\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Case_Reports2017_0.pdf."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0832","article-title":"Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa","volume":"162","author":"Karczewska-Kupczewska M","year":"2010","unstructured":"Karczewska-Kupczewska M, Straczkowski M, Adamska A, Nikolajuk A, Otziomek E, G\u00f3rska M, Kowalska I. Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa. Eur J Endocrinol. 2010, 162:235-9. 10.1530\/EJE-09-0832","journal-title":"Eur J Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/475161-severe-nondiabetic-hypoglycemia-after-risperidone-initiation-in-an-adult-with-schizophrenia-a-case-report-and-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T02:44:21Z","timestamp":1775357061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/475161-severe-nondiabetic-hypoglycemia-after-risperidone-initiation-in-an-adult-with-schizophrenia-a-case-report-and-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.106442","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,4]]}}}